Eurofins Launches Coronavirus Testing Solutions

Eurofins Technologies has launched GeneScan VIRSeek SARS-CoV-2 RT-PCR, an integrated solution including RNA extraction and test kits based on real-time RT-PCR (Reverse transcription polymerase chain reaction) for the detection of SARS-CoV-2 in swabs of environmental surfaces.
 
Recently published studies suggest that SARS-CoV-2 may remain viable on different surfaces for up to 72 hours. The comprehensive VIRSeek suite of test kits and workflows provides customers with fast tests to broadly screen for the presence of SARS-CoV-2, as well as verification of results with an independent test. This will enable organizations in diverse industries, as well as in healthcare, transport and many other environments to help test, determine, monitor and eventually strengthen the effectiveness of sanitation measures put in place, ultimately contributing to increased health and safety in these respective environments.
 
"We are pleased to provide companies and health authorities with options to test for the presence of SARS-CoV-2 in their environments and believe that this solution can potentially play an important role in the documented effectiveness of sanitation procedures and hygiene monitoring," said Gilles Martin, chief executive officer, Eurofins Scientific. "It is planned that this kit will also be used by hundreds of Eurofins testing laboratories around the world to offer fast turnaround testing services to support their clients’ needs wherever necessary."

Register as Visitor to CPhI China 2020!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the articles,

please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.